Covered recipient · General Payments record
ANNEMARIE LAURRI BANNISTER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,008.55
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.63 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $52.39 | 3 |
| GlaxoSmithKline, LLC. | $36.36 | 2 |
| Novo Nordisk AS | $34.36 | 2 |
| Lilly USA, LLC | $31.14 | 2 |
| ABBVIE INC. | $27.51 | 1 |
| PFIZER INC. | $24.78 | 1 |
| IBSA Pharma Inc. | $18.76 | 1 |
| Astellas Pharma US Inc | $18.27 | 1 |
| Currax Pharmaceuticals LLC | $15.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.51 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103276189 | CMS |
| Astellas Pharma US Inc | $18.27 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139266782 | CMS |
| Currax Pharmaceuticals LLC | $15.06 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089509090 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.52 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101413403 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.79 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101413415 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.08 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101413437 | CMS |
| GlaxoSmithKline, LLC. | $19.85 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116363865 | CMS |
| GlaxoSmithKline, LLC. | $16.51 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116381694 | CMS |
| IBSA Pharma Inc. | $18.76 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142988216 | CMS |
| Lilly USA, LLC | $16.97 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136045395 | CMS |
| Lilly USA, LLC | $14.17 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136045393 | CMS |
| Novo Nordisk Inc | $18.10 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096910239 | CMS |
| Novo Nordisk Inc | $16.26 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096681224 | CMS |
| PFIZER INC. | $24.78 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131089403 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.